3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Psychiatric Rehabilitation
8
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Capecitabine
7
pembrolizumab
6
Early Intervention, Educational
6
Drug Therapy
6
Cyclophosphamide
6
Methods
5
Therapeutics
4
Specimen Handling
4
Mental Status and Dementia Tests
4
Docetaxel
4
veliparib
3
selpercatinib
3
sargramostim
3
palbociclib
3
cediranib
3
Trastuzumab
3
Surveys and Questionnaires
3
Standard of Care
3
Radiotherapy
3
Paclitaxel
3
Oxaliplatin
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Counseling
3
Cisplatin
3
Carboplatin
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Rivaroxaban
×
Breast
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled